Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Advances in Therapy

• Publication date

  2009-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12325-009-0005-xPMID 19259630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris

  2012cited by this paper
• European Public Assessment Report (EPAR)

  2009cited by this paper
• Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• A review of postural orthostatic tachycardia syndrome.

  2008cited by this paper
• Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

  2008cited by this paper
• Coronary heart disease statistics.

  2008cited by this paper
• Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine.

  2007cited by this paper
• Long-Term Safety and Efficacy of Ivabradine in Patients with Chronic Stable Angina

  2007cited by this paper
• Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology.

  2006cited by this paper
• Guidelines on the management of stable angina pectoris.

  2006cited by this paper
• Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.

  2005cited by this paper
• If channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities

  2004cited by this paper
• Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

  2004cited by this paper
• Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial

  2003cited by this paper
• The current cost of angina pectoris to the National Health Service in the UK

  2003cited by this paper
• Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs

  2003cited by this paper
• If inhibition: a novel mechanism of action

  2003cited by this paper
• Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.

  2001cited by this paper
• Changes in heart rate and heart rate variability before ambulatory ischemic events

  2001cited by this paper
• Changes in heart rate and heart rate variability before ambulatory ischemic events(1).

  2001cited by this paper
• Chronic Ischemic Heart Disease

  2001cited by this paper
• Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): a study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risks.

  2000cited by this paper
• alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans.

  2000cited by this paper
• Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues.

  1999cited by this paper
• Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

  1999cited by this paper
• Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial

  1997cited by this paper
• Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.

  1997cited by this paper
• Percutaneous Transluminal Coronary Angioplasty Versus Medical Therapy for Stable Angina Pectoris: Outcomes for Patients With Double-Vessel Versus Single-Vessel Coronary Artery Disease in a Veterans Affairs Cooperative Randomized Trial

  1997cited by this paper
• Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS.

  1997cited by this paper
• Textbook of Cardiovascular Medicine

  1997cited by this paper
• Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

  1994cited by this paper
• Electrophysiological effects of S 16257, a novel sino‐atrial node modulator, on rabbit and guinea‐pig cardiac preparations: comparison with UL‐FS 49

  1994cited by this paper
• A Comparison of Angioplasty With Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease

  1992cited by this paper
• A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

  1992cited by this paper
• Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS)

  1990cited by this paper
• Practical management of ischaemic heart disease

  1988cited by this paper
• The Cardiovascular System

  1983cited by this paper
• Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies.

  1980cited by this paper
• Measurement and significance of the reversal potential for the pace‐maker current (iK2) in sheep Purkinje fibres.

  1979cited by this paper

• Tablet Compression Optimization of Ivabradine Sustained-Release Tablet Using Full Factorial Design

  2024cites this paper
• Development and Validation of UV-Vis Spectroscopy Method for the Determination of Ivabradine Hydrochloride and Metoprolol Succinate in Tablet Dosage Form

  2020cites this paper
• Fabrication and evaluation of pH-dependent polymeric microspheres of ivabradine and their in vitro and in vivo studies

  2018cites this paper
• Pharmacokinetics changes of ivabradine and N-desmethylivabradine after oral administration with puerarin in rats

  2016cites this paper
• Medical Management of Chronic Stable Angina

  2015cites this paper
• The effect of clopidogrel on pharmacokinetics of ivabradine and its metabolite in rats

  2015cites this paper
• Rapid and Selective UV Spectrophotometric and RP-HPLC Methods for Dissolution Studies of Ivabradine Controlled-Release Formulations

  2014cites this paper
• Challenges with Nitrate Therapy and Nitrate Tolerance: Prevalence, Prevention, and Clinical Relevance

  2014cites this paper
• Heart rate as a therapeutic target in angina pectoris.

  2013cites this paper
• Stable angina pectoris: the medical management of symptomatic myocardial ischemia.

  2012cites this paper
• Pharmacokinetic Interaction between Ivabradine and Phenytoin in Healthy Subjects

  2012cites this paper
• Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation

  2012cites this paper
• Pharmacokinetic interaction between ivabradine and phenytoin in healthy subjects.

  2012cites this paper
• Pharmacodynamic effects of ivabradine, a negative chronotropic agent, in healthy cats.

  2011cites this paper
• Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.

  2011cites this paper
• Ivabradine: Just another New Pharmacological Option for Heart Rate Control?

  2011cites this paper
• Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers

  2011cites this paper
• Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets

  2010cites this paper
• Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets

  2010cites this paper
• PHARMACOKINETIC INTERACTION STUDY BETWEEN IVABRADINE WITH FLUOXETINE OR METRONIDAZOLE IN HEALTHY VOLUNTEERS

  2010cites this paper
• Elevated heart rate in cardiovascular diseases: a target for treatment?

  2009cites this paper